EFFICACY OUTCOMES OF PLACEBO MAINTENANCE TREATMENT IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS WHO RESPONDED TO PLACEBO INDUCTION THERAPY: RESULTS FROM THE PHASE 3 COMMAND STUDY

被引：0
|
作者：
Atreya, Raja
Ferrante, Marc
Afzali, Anita
Bamias, Giorgos
Long, Millie D.
Neimark, Ezequiel
Levine, Phillip
Cheng, Ling
Kalabic, Jasmina
Hecht, Patrick
Vladea, Ramona C.
Schreiber, Stefan
机构：
来源：
GASTROENTEROLOGY | 2024年 / 166卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Su1792
引用
收藏
页码：S815 / S816
页数：2
相关论文
共 50 条
  • [31] Induction and Maintenance Treatment With Upadacitinib Improves Health-Related Quality of Life in Patients With Moderately to Severely Active Ulcerative Colitis: Phase 3 Study Results
    Panes, Julian
    Loftus, Edward, V
    Higgins, Peter D. R.
    Lindsay, James O.
    Zhou, Wen
    Yao, Xuan
    Ilo, Dapo
    Phillips, Charles
    Tran, Jacinda
    Sanchez Gonzalez, Yuri
    Vermeire, Severine
    INFLAMMATORY BOWEL DISEASES, 2023, : 1421 - 1430
  • [32] Early Symptomatic Improvement With Guselkumab Induction Treatment in Moderately to Severely Active Ulcerative Colitis: Results From the Phase 3 QUASAR Induction Study
    Lichtenstein, Gary R.
    Dignass, Axel
    Rubin, David T.
    Yarandi, Shadi
    Huang, Kuan-Hsiang G.
    Germinaro, Matthew
    Miao, Ye
    Zhang, Hongyan
    Kierkus, Jaroslaw
    Seidler, Ursula
    Maemoto, Atsuo
    Allegretti, Jessica R.
    Bressler, Brian
    Peyrin-Biroulet, Laurent
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S623 - S624
  • [33] Efficacy of Risankizumab Maintenance Therapy by Clinical Remission and Endoscopic Improvement Status in Patients With Moderately to Severely Active Ulcerative Colitis: Post Hoc Analysis of the COMMAND Phase 3 Study
    Panaccione, Remo
    Bossuyt, Peter
    Blumenstein, Irina
    Biedermann, Luc
    Torres, Joana
    Vladea, Ramona
    Cheng, Ling
    Zhang, Yafei
    Kalabic, Jasmina
    Chien, Karen
    Morisset, Pierre
    Parkes, Gareth
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S1060 - S1060
  • [34] Etrasimod as induction and maintenance therapy in Asian patients with moderately to severely active Ulcerative Colitis: Results from the maintenance period of a randomised, double-blind, placebo-controlled, multi-centre Phase 3 study (ES101002)
    Wu, K.
    Zheng, C.
    Cao, Q.
    Gao, X.
    Ding, Y.
    Zhong, J.
    Zhang, H.
    Wang, X.
    Wang, B.
    Zhang, Z.
    Wang, N.
    Cao, X.
    Ye, L.
    Liang, J.
    Liu, X.
    Zhou, Y.
    Chiu, C. T.
    Kim, T. O.
    Chou, J. W.
    Xu, B.
    Shen, X.
    Chen, D.
    Chen, W. C.
    Liu, Y.
    Shen, J.
    Liu, F.
    Zhan, Q.
    Ding, X.
    Zeng, S.
    Lin, Y.
    Ying, L.
    Chen, X.
    JOURNAL OF CROHNS & COLITIS, 2025, 19 : i182 - i184
  • [35] The Efficacy of Maintenance Treatment with Guselkumab in Patients With Moderately to Severely Active Ulcerative Colitis: Phase 3 QUASAR Maintenance Study Results at Week 44 by Biologic/Janus Kinase History
    Allegretti, Jessica R.
    Panes, Julian
    Peyrin-Biroulet, Laurent
    Sands, Bruce E.
    Yarandi, Shadi
    Huang, Kuan-Hsiang G.
    Germinaro, Matthew
    Zhan, Jia
    Zhang, Hongyan
    Begun, Jakob
    Kierkus, Jaroslaw
    Kravchenko, Tetiana
    Hisamatsu, Tadakazu
    Rubin, David T.
    Bressler, Brian
    Dignass, Axel
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S882 - S882
  • [36] Histologic and Combined Histologic and Endoscopic Outcomes After Guselkumab Maintenance Therapy in Patients With Moderately to Severely Active Ulcerative Colitis: Week 44 Results From the Phase 3 QUASAR Maintenance Study
    Panes, Julian
    Dignass, Axel
    Hisamatsu, Tadakazu
    Yarandi, Shadi
    Huang, Kuan-Hsiang G.
    Germinaro, Matthew
    Sridhar, Sunandini
    Branigan, Patrick
    Wilson, Rebbecca
    Zhang, Hongyan
    Magro, Fernando
    Jairath, Vipul
    Feagan, Brian G.
    Lichtenstein, Gary R.
    Rubin, David T.
    Sands, Bruce E.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S1041 - S1041
  • [37] THE EFFICACY AND SAFETY OF GUSELKUMAB INDUCTION THERAPY IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: PHASE 213 QUASAR STUDY RESULTS THROUGH WEEK 12
    Allegretti, Jessica R.
    Rubin, David T.
    Bressler, Brian
    Huang, Kuan-Hsiang G.
    Shipitofsky, Nicole
    Germinaro, Matthew
    Zhang, Hongyan
    Johanns, Jewel
    Feagan, Brian
    Sandborn, William J.
    Sands, Bruce E.
    Hisamatsu, Tadakazu
    Lichi, Gary R.
    Lichtenstein, Gary R.
    Panes, Julian
    Dignass, Axel
    GASTROENTEROLOGY, 2022, 162 (07) : S963 - S964
  • [38] A Phase 2 Study Design to Investigate the Efficacy and Safety of Dupilumab Therapy Compared With Placebo in Adults With Moderately to Severely Active Ulcerative Colitis With an Eosinophilic Phenotype
    Binion, David
    Feagan, Brian G.
    Mortensen, Eric
    Laws, Elizabeth
    Maloney, Jennifer
    Martincova, Renata
    Radin, Allen
    Glotfelty, Lila
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2023, 118 (10): : S159 - S160
  • [39] Efficacy of Upadacitinib Induction Therapy in Patients With Moderately to Severely Active Ulcerative Colitis by Biologic Inadequate Responder Status: Results From Two Randomized Phase 3 Studies
    Vermeire, Severine
    Tanida, Satoshi
    Hu, Renwei
    Panaccione, Remo
    Hebuterne, Xavier
    Rubin, David T.
    Ilo, Dapo
    Zhou, Wen
    Weinreich, Michael
    Zhou, Qing
    Danese, Silvio
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2021, 116 : S398 - S399
  • [40] Effects of Immunomodulators on the Pharmacokinetics and Efficacy of Golimumab in Patients with Moderately to Severely Active Ulcerative Colitis: Results from Phase 2/3 PURSUIT-SC Induction and Maintenance Studies
    Adedokun, Omoniyi
    Xu, Zhenhua
    Marano, Colleen
    Strauss, Richard
    Zhang, Hongyan
    Johanns, Jewel
    Ford, Joyce
    Zhou, Honghui
    Davis, Hugh
    Colombel, Jean-Frederic
    Reinisch, Walter
    Feagan, Brian
    Rutgeerts, Paul
    Sandborn, William
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2013, 108 : S517 - S517
12345